Atjaunināt sīkdatņu piekrišanu

Case Studies: Stahl's Essential Psychopharmacology: Volume 3 [Mīkstie vāki]

Edited by (University of California, Riverside), Edited by (University of California, San Diego), Edited by (University of California, Riverside)
  • Formāts: Paperback / softback, 448 pages, height x width x depth: 227x139x18 mm, weight: 640 g, Worked examples or Exercises
  • Izdošanas datums: 18-Nov-2021
  • Izdevniecība: Cambridge University Press
  • ISBN-10: 1009012894
  • ISBN-13: 9781009012898
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 80,72 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
Case Studies: Stahl's Essential Psychopharmacology: Volume 3Palielināt
  • Formāts: Paperback / softback, 448 pages, height x width x depth: 227x139x18 mm, weight: 640 g, Worked examples or Exercises
  • Izdošanas datums: 18-Nov-2021
  • Izdevniecība: Cambridge University Press
  • ISBN-10: 1009012894
  • ISBN-13: 9781009012898
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781009012898.html
Keywords:
Following the success of the first two volumes in Stahl's Case Studies series, a brand new collection of clinical stories have been collated in Volume 3, derived from cases seen by medical students, residents and faculty from the University of California at Riverside (UCR) Department of Psychiatry and Neuroscience. The highly popular and unique user-friendly presentation of previous volumes has been maintained, with extensive use of icons, questions/answers, and tips. The cases address multifaceted issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life.

For the third volume in Stahl's Case Studies series, Dr. Stahl partners with UCR School of Medicine faculty colleagues, residents and medical students to present new psychiatric cases addressing complex issues of direct relevance to the everyday experience of the clinician. Essential reading for all mental health professionals and students.

Recenzijas

'I am delighted to see the new volume. It is a very welcome, important complement to Stahl's Essential Psychopharmacology. While presenting several interesting and timely cases that will allow practitioners in mental health to hone their skills and update their psychopharmacology knowledge, it is also a delightful read. Well done!' Jair C. Soares, Professor and Chairman, Pat Rutherford Chair in Psychiatry, Director, UT Center of Excellence on Mood Disorders, Louis Faillace, M.D Department of Psychiatry and Behavioral Sciences, UT Houston Medical School, Houston, USA 'This book offers readers a comprehensive approach to complex, real world psychopharmacological dilemmas based on actual clinical cases that are followed over time. Each case identifies critical questions at important junctures of treatment and expertly breaks down the thought processes involved in decision making of challenging yet common and recognizable clinical scenarios. The authors demonstrate how to apply the art and science of psychopharmacology with careful in-depth dissections of each case, outside of the box thinking and a large dose of humility. Readers will appreciate the case discussions where authors share their confessions as psychopharmacologists and retrospective self-assessments of what they could have done better. Case Studies: Stahl's Essential Psychopharmacology distils years of clinical experience with up-to-date clinical psychopharmacology into a practical text for all psychiatric practitioners.' Poh Choo How, MD, PhD, Assistant Professor, Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento

Papildus informācija

A brand new selection of clinical stories covering psychiatric treatments that work and fail, and mistakes made along the journey.
Introduction xiii
Contributors xvii
List of icons
xix
Abbreviations xxi
1 The Case: Wearing down a diagnosis
1(12)
The Question: What are the similarities and differences between anxiety and autism spectrum disorder (ASD) in children? How does it affect treatment and prognosis?
The Psychopharmacological Dilemma: Does this patient have an anxiety disorder, which can be treated effectively with a simple regimen that has a good prognosis, or does she have an ASD, which would require a more extensive regimen and possible lifelong treatment?
Karen Clarey, Stephanie Wong, and Takesha Cooper
2 The Case: The woman who couldn't handle her lips smacking any longer
13(12)
The Question: Is tardive dyskinesia permanent?
The Psychopharmacological Dilemma: Finding various options for treating tardive dyskinesia
Douglas Grover, Michael T. Ingram, Jr., and Christopher G. Fichtner
3 The Case: The depressed bipolar patient on multiple medications
25(12)
The Question: Can reduction of polypharmacy optimize mood stabilization and reduce risk of subsequent manic or depressive episodes in this patient?
The Psychopharmacological Dilemma: Starting new medications and altering current ones can give rise to new adverse effects
Dale Hoang, Catherine Ha, and Peter Hauser
4 The Case: The agitated patient who finally wasn't
37(12)
The Question: What do you do when a patient is taking appropriate scheduled medications, but is frequently agitated and requiring medication intramuscularly (IM) or as needed on top?
The Psychopharmacological Dilemma: This patient had a significant history of violence and required heavy utilization of emergency medications in addition to scheduled medications. How do you balance the safety needs of the patient and staff while still respecting consent, ethicalrights, and the risk of serious side effects?
Alex J. Mageno, Nekisa Haghighat, and Arthur Leitzke
5 The Case: The George who was not psychotic but anxious and distracted
49(12)
The Question: How common is psychosis seen in the spectrum of psychiatric comorbidities in DiGeorge syndrome?
The Psychopharmacological Dilemma: Treating anxiety in a patient with a comorbid medical condition, symptoms of mood elevation, and a family history of bipolar disorder
Edgar Ortega, Michael Seigler, and Takesha Cooper
6 The Case: The man who saw enemies everywhere
61(10)
The Question: What treatment options are left when nearly all treatments have been exhausted and ineffective?
The Psychopharmacological Dilemma: Treating symptoms recalcitrant to even the most robust treatment strategies Joshua Poole and Stephen Maurer
7 The Case: The young woman with psychosis complicated by substance use and a history of traumatic brain injury
71(14)
The Question: How do you determine whether psychosis is a primary or secondary illness?
The Psychopharmacological Dilemma: Does treatment depend upon whether psychosis is due to a primary psychiatric illness?
Harika Reddy, Austin Nguy, and Sana Johnson-Quijada
8 The Case: The woman with worsening psychosis and a mysterious rash
85(10)
The Question: What do you do when a psychiatric patient on steroids develops psychosis?
The Psychopharmacological Dilemma: How to address steroid-induced psychiatric disorders
Sireena Sy, Yatna Patel, and Alexander Thanh Nguyen
9 The Case: The man without a plan
95(8)
The Question: How to diagnose and treat a patient with a coexisting attention-deficit/hyperactivity disorder (ADHD) and mood symptoms?
The Psychopharmacological Dilemma: Finding an effective medication regimen for a patient previously diagnosed with ADHD and major depressive disorder failing selective serotonin reuptake inhibitors
Alfonso Vera and Gerald Maguire
10 The Case: The anxious depressed woman who couldn't sit still
103(12)
The Question: How can you distinguish between bipolar disorder with mixed features and major depressive disorder with mixed features? Is it necessary to differentiate between the two?
The Psychopharmacological Dilemma: Finding an effective regimen for recurrent, anxious depression while minimizing akathisia
Nekisa Haghighat, Charity Hall, Dennis Alters, and Gerald Maguire
11 The Case: The man who thinks it's the end of the world
115(12)
The Question: Can a pandemic trigger dormant psychiatric symptoms?
The Psychopharmacological Dilemma: If some element of psychosis is personality driven, will the patient benefit from medication therapy or psychotherapy to alleviate symptoms?
Erin Fletcher, Evagelos Coskinas, and Phuong Vo
12 The Case: Sunny with a chance of depression
127(10)
The Question: Can stimulants be used in the treatment of major depressive disorder?
The Psychopharmacological Dilemma: How to treat recurrent major depression in patients who are resistant to various treatments and have specific comorbidities
Madeline Saavedra, Bo Ram Yoo, Douglas Grover, and Christopher G. Fichtner
13 The Case: A not-so-simple case of anxiety
137(8)
The Question: What should you do when a patient with no history of mental illness presents with sudden psychiatric complaints, significant behavioral changes, and a variety of physical symptoms?
The Psychopharmacological Dilemma: How to appropriately evaluate patients presenting with a broad range of symptoms, including physical, psychiatric and behavioral, in order to prevent misdiagnosis of a disease
Karla P. Furlong, Roberto Castanos, and Bo Ram Yoo
14 The Case: I'm a woman in a man's body
145(10)
The Question: I'm not a specialist in this area. What can I do to help recognize and alleviate gender dysphoria?
The Psychopharmacological Dilemma: Finding an effective regimen for the treatment of gender dysphoria while juggling with comorbid depression and anxiety
Sarah Grace, Matt Jason V. Llamas, and Jami Woods
15 The Case: The spacey, fidgety son with overwhelming sadness
155(16)
The Question: How to manage adolescent depression with comorbid attention-deficit/hyperactivity disorder (ADHD)?
The Psychopharmacological Dilemma: Being cognizant of possible drug interactions when selecting antidepressants in adolescents who also require treatment for ADHD
Niya Larios, Casey Lester, and Carl Feinstein
16 The Case: The man who spent thousands online
171(16)
The Question: Can antiemetics play a role in the treatment of psychiatric disease?
The Psychopharmacological Dilemma: How to diagnose and treat sedative-hypnotic use disorder in an elderly patient who is sensitive to medications
Saloni Singh and Carla Hammond
17 The Case: The traumatized mother who can't stop bingeing
187(10)
The Question: How do you treat refractory binge eating?
The Psychopharmacological Dilemma: Will the treatment of trauma and mood disorders help resolve this patient's binge eating, or is something more needed?
Kevin Simonson and Bo Ram Yoo
18 The Case: The man who couldn't stop hitting people
197(18)
The Question: Is there a way to further optimize treatment of violent, psychotic agitation safely beyond the combination of clozapine
(Clozaril) with a mood stabilizer in someone with significant cardiovascular history?
The Psychopharmacological Dilemma: How to reduce violent, psychotic behaviors in someone with an inadequate response to multiple empirical combinations of medications for treatment-resistant schizophrenia with behavioral agitation
Angharad Ames and Lawrence Faziola
19 The Case: Brexpiprazole: "an awakening"
215(12)
The Question: Can the addition of brexpiprazole (Rexulti) to clozapine
(Clozaril) reduce positive symptoms in a patient who has not fully responded to clozapine alone?
The Psychopharmacological Dilemma: Can "third-generation" antipsychotics, such as brexpiprazole, be utilized in combination with clozapine for treatment-resistant psychosis?
Troy Kurz, Lauren Kurz, and Samer Kamal
20 The Case: Treatment-resistant depression and opioid dependence
227(10)
The Question: How can we pharmacologically address refractory major depressive disorder in a patient on buprenorphine-naloxone (Suboxone) maintenance for opioid dependency?
The Psychopharmacological Dilemma: Does ketamine interact with buprenorphine-naloxone?
Kevin Simonson and Alexander H. Truong
21 The Case: A stiff patient
237(14)
The Question: What are the main clinical considerations when discontinuing clozapine (Clozaril) due to side effects?
The Psychopharmacological Dilemma: How to improve quality of life and minimize medication side effects in a patient with medication-resistant psychotic symptoms
Angharad Ames, Joshua Valverde, and Gerald Maguire
22 The Case: An adolescent awakening
251(18)
The Question: How to manage an adolescent with treatment-resistant psychosis, underlying attention deficit hyperactivity disorder (ADHD) symptoms, daytime sedation, insomnia, and a propensity for weight gain?
The Psychopharmacological Dilemma: Finding an effective regimen for treatment-resistant psychosis in an adolescent while managing underlying ADHD symptoms, daytime sedation, insomnia, and weight gain
Monish Parmar and Richard J. Lee
23 The Case: The peace keeper with a left breast mass
269(10)
The Question: How can neutrophil count be monitored effectively in a patient early in clozapine (Clozaril) treatment who is also undergoing simultaneous chemotherapy?
The Psychopharmacological Dilemma: How to use the guidelines of the clozapine registration system to effectively monitor absolute neutrophil count in a patient currently taking clozapine for treatment-resistant schizophrenia while simultaneously undergoing chemotherapy?
Diem Nguyen and Brenda Jensen
24 The Case: The girl who slept with problems
279(12)
The Question: What is a treatment approach for insomnia in children with trauma and comorbid psychiatric conditions?
The Psychopharmacological Dilemma: There is limited data regarding the safety and efficacy of medications for sleep promotion in children and adolescents, especially those with trauma
Joseph Yasmeh and Ijeoma Ijeaku
25 The Case: Not all child's play: a path to pediatric stability
291(16)
The Question: What can you do to manage symptoms and achieve long-term stability in a pediatric patient with multiple psychiatric conditions?
The Psychopharmacological Dilemma: Finding an effective medication regimen for a complex pediatric patient with multiple diagnoses and previous hospitalizations
Joseph Wong, Justine Ku, and Takesha Cooper
26 The Case: The young woman who was "nothing but skin and bones"
307(18)
The Question: What is the most likely diagnosis?
The Psychopharmacological Dilemma: How to distinguish anorexia nervosa from other possible diagnoses and formulate a plan of treatment
Kayla L. Fisher and Michelle Tom
27 The Case: Could it be both? Comorbid psychiatric diagnoses
325(12)
The Question: How do you distinguish between poor academic performance due to attention-deficit/hyperactivity disorder (ADHD) versus a specific learning disorder versus both? The Psychopharmacological Dilemma: Utilizing the biopsychosocial model to provide holistic treatment and improve patient quality of life
Ruqayyah Malik, Margaret Yau, and Dennis Alters
28 The Case: Treatment-emergent mania/fiypomania in a depressed patient
337(12)
The Question: Can you observe manic/hypomanic side effects in a unipolar depression case after starting antidepressants?
The Psychopharmacological Dilemma: How careful should you be with antidepressants if you suspect unipolar depression versus bipolar depression when starting treatment?
Kevin Truong and Lawrence Yu
29 The Case: The border between mood and personality
349(14)
The Question: Can you differentiate between borderline personality traits (disorder) from a recurring mood disorder such as major depressive disorder (MDD)?
The Psychopharmacological Dilemma: Is it necessary to differentiate between borderline personality traits (disorder) and major depressive disorder in a teenager?
Phuong Vo and Ijeoma Ijeaku
30 The Case: The student who wanted to go to rehab
363(12)
The Question: How do you manage a patient with benzodiazepine withdrawal seizure?
The Psychopharmacological Dilemma: How to delineate whether the patient has benzodiazepine withdrawal psychosis or cannabis-induced psychosis in an 18-year-old male who presented with seizure
Eduardo Javier, Louis May, and Martin Sahakyan
31 The Case: The boy who wouldn't (couldn't) listen
375(12)
The Question: What do you do when nothing you try works?
The Psychopharmacological Dilemma: How to achieve diagnostic clarity and treatment simplicity through layers of reported symptoms in a child
Alex J. Mageno, Bo Ram Yoo, and Richard J. Lee
32 The Case: The patient who went streaking
387(12)
The Question: Is the patient having delirium tremens or is something else going on?
The Psychopharmacological Dilemma: Agitation: methamphetamine withdrawal delirium versus Benzodiazepine disinhibition syndrome
Louis May, Martin Sahakyan, and Eduardo Javier
33 The Case: "Perseverance"
399(14)
The Question: The patient with a history of anxiety, mood lability, hypomanic symptoms, psychotic symptoms, history of substance abuse, medical issues, and multiple failed trials of medications due to side effects from medication. What is the diagnosis and how should it be managed? What medications should be used to treat bipolar disorder with mixed episodes?
The Psychopharmacological Dilemma: How to manage multiple failed trials of medications from different classes, with initial benefit but then loss of effect
Kathleen Lopez, Courtney DiNicola, and Niraj Gupta
34 The Case: Clozapine (Clozaril) candidate discombobulates compassionate clinicians
413(10)
The Question: How soon is too soon to consider clozapine utilization in a patient with polymorphic symptoms? The patient presents with residual symptoms of psychosis, which included delusions and hallucinations. He has been diagnosed with schizophrenia in the past and has failed multiple trials of psychotropic medication due to side effects. Does this patient need diagnostic clarification and how should this be further managed? The Psychopharmacological Dilemma: The patient has failed trials of multiple medications in different classes, noting only transient efficacy
Darian Vernon, Nishant Prakash, and Niraj Gupta
Index of drug names 423(3)
Index of case studies 426
Takesha J. Cooper, MD, MS is an associate clinical Professor of Psychiatry at the University of California Riverside School of Medicine and serves as the program director of the Psychiatry residency training program. Gerald A. Maguire, MD is a Professor and Chair of Psychiatry and Neuroscience at the University of California Riverside School of Medicine. Stephen M. Stahl, MD is Adjunct Professor of Psychiatry at the University of California, San Diego, Clinical Professor of Psychiatry and Neuroscience at the University of California, Riverside, and Honorary Visiting Senior Fellow in Psychiatry at the University of Cambridge.